ABSTRACT
C for 24 h. On the basis of the obtained weights the percentage of organic and non-organic components were calculated.

The results obtained revealed that ovariectomy produced a significant reduction in bone mineral density (BMD), dry weight, ash content, femoral calcium content and organic matrix weight compared to the control group, indicating that there was a decrease in bone mass rather than a decrease in bone minerals. Serum calcium concentration did not show any significant change following OVX, serum calcitonin level decreased after OVX and increased with estrogen supplementation. The combination groups which were supplemented either with (estrogen and progesterone) or with (calcitonin and calcium) -with insignificant differences between them-increased BMD, dry weight, ash content, organic matrix weight and ash
INTRODUCTION
Bone is a dynamic tissue, being formed and resorbed continually under the control of hormonal and physical factors. Remodeling of bone takes place throughout life, with osteoclasts resorbing old bone and osteoblasts creating new bone. These cells continuously renew the skeleton while maintaining its strength and density. Normally, in the adult skeleton, 3% of cortical bone and 25% of trabecular bone are remodeled each year. An imbalance between these processes may result in loss of bone mass (1) . Osteoporosis is characterized by low bone mass and micro architectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. The major cause of that disease is cessation of ovarian function after menopause. Estrogen deficiency in mammals increases bone turnover and results in a reduction in bone mass due to an imbalance between bone resorption and bone formation. OVX rats have been widely used as an animal model for the study of the prevention and treatment of postmenopausal osteoporosis. There are many observed similarities between ovariectomy-induced bone loss in rats and postmenopausal bone loss in humans (2) . Several pharmacological agents are available for prevention and treatment of osteoporosis, and they can be classified according to their mechanism of action. The two main classes of drugs used to treat osteoporosis are: the antiresorptive agents that block bone resorption by inhibiting the activity of osteoclasts and the anabolic agents that stimulate bone formation by acting primarily on osteoblasts and the antiresorptive drugs include estrogens, bisphosphonates and calcitonin. In contrast to drugs that slow bone turnover, anabolic agents directly stimulate bone formation; these drugs include parathyroid hormone, growth hormone, and sodium fluoride (3) . The aim of the present work was to study the effects of ovariectomy on calcium metabolism with or without elementary substitution and to compare the results with those of hormonal replacement therapy. The effects of estrogen and progesterone supplementation will, also, be differentiated.
MATERIALS & METHODS
Ninety adult female albino rats, weighing 200-250 g were used in the study. Rats ) of bones from small animals. Density was calculated using the formula: Density =W/W-WW X PWhere, P is the density of distilled water at a given temperature and W-WW is the difference in weight, which is equivalent to the bone volume (10) .
4-Preparation of dried femurs:
The left femurs were first dried to constant weight at 100°C for 24 h and weighed again for the determination of dry weight (DW) which includes organic, minerals, and fat as the water content was only evaporated. On the basis of the obtained initial weights of femur; W and DW, the weight of water content in the femurs was calculated using the 
RESULTS
1-Effect of ovariectomy on left femur parameters:
All left femur parameters in the OVX group had significantly lower values than those from the control except, % of water content which showed a significant higher level in the OVX group compared with the control group with insignificant difference of the ratio between the non organic to the organic component between the two groups. This is illustrated in table (1) 2-Effect of ovariectomy with estrogen supplementation on left femur parameters:
There were insignificant differences in all left femur parameters between the OVX+E group and the control group except the BMD which showed a significant lower value in the OVX+E group. There were significant higher values in all left femur parameters in the OVX+E group compared to the OVX group except % of water content which showed a significant lower value with insignificant difference in the ratio of non organic to organic component between the two groups. This is shown in table (1).
3-Effect of ovariectomy with progesterone supplementation on left femur parameters:
There were significant lower values of ash weight and BMD in the OVX+P group compared to the control group with insignificant difference in the other parameters between the two groups. There were significant higher values in all left femur parameters in the OVX+P group compared to the OVX group except % of water content and the ratio of non organic to organic component which showed significant lower values. This is illustrated in table (1). 4-Effect of ovariectomy with estrogen and progesterone supplementation on left femur parameters:
There were significant higher values in all left femur parameters in the OVX+E+P group compared to the OVX group except % of water content which showed a significant lower value with insignificant difference in the ratio of non organic to organic component between the two groups. This is illustrated in table (1).
5-Effect of ovariectomy with calcium supplementation on left femur parameters:
There were insignificant differences in all left femur parameters between the OVX+Ca group and the OVX group. All femurs of the OVX+Ca group had significantly lower values than those from the control except % of water content which showed a significant higher level in the OVX+Ca group compared with the control group with insignificant difference in the ratio of non organic to organic component between the two groups. This is shown in table (2).
6-Effect of ovariectomy with calcitonin supplementation on left femur parameters.
There were insignificant differences in all left femur parameters between the OVX+Cal group and the control group except the BMD which showed a significant lower value in the OVX+Cal group. There were significant higher values in all left femur parameters in OVX+Cal group compared to the OVX group except % of water content which showed a significant lower value and insignificant difference in the ratio of non organic to organic component between the two groups. This is illustrated in table (2). 7-Effect of ovariectomy with calcitonin and calcium supplementation on left femur parameters:
There were significant higher values in all left femur parameters in the OVX+Ca+Cal group compared to the OVX group except % of water content which showed a significant lower value with insignificant difference in the ratio of non organic to organic component between the two groups. This is illustrated in table (2).
8-Effect of ovariectomy with vitamin D supplementation on left femur parameters:
There were significant higher values in all left femur parameters in OVX+vit D group compared to the OVX group except % of water content which showed a significant lower value with insignificant difference in the ratio of non organic to organic component between the two groups. This is illustrated in table (3).
9-Changes in femur calcium and phosphorus content in different groups:
There were significant lower levels of femoral calcium content of the OVX, OVX+Ca and OVX+P groups compared to control group. Other ovariectomized treated groups had femoral calcium content levels that were similar to those of the control group. This is shown in table (4).
There was insignificant change in femoral phosphorus content in the ovariectomized and the ovariectomized treated groups compared with control group. This is illustrated in table (4). 10-Effects of treatment of different drug therapies on serum calcium, phosphorus, parathormone and calcitonin in different groups (Table  5) :
There was insignificant change in serum calcium levels in OVX and the ovariectomized treated groups compared with the control group except, OVX+Cal group in comparison to all other groups.
There was significant higher serum phosphorus concentration in OVX group compared to control group, while, other ovariectomized treated groups had serum phosphorus concentrations that were similar to those of the control group.
There was insignificant change in serum parathormone levels in OVX and the ovariectomized treated groups compared with control group.
The OVX group and OVX+Ca group showed significant lower serum calcitonin level compared with the control group. In all supplemented ovariectomized groups, there was a significant higher value in serum calcitonin level compared with the OVX group.
11-Effect of treatment with different drug therapies on BMD:
The ovariectomized group showed the lowest bone density between all groups compared with the control group. Ovariectomy resulted in 15.5% decrease in BMD of left femurs. The calcium supplemented ovariectomized group had insignificant difference with the ovariectomized group. When it is compared with the control group, there was a significant reduction by 14.37%. The highest increase BMD was observed among the combination groups which supplemented either with (estrogen and progesterone) or with (calcitonin and calcium). The percentage changes were 18% and 17.3% respectively, as compared to OVX group. This is illustrated in figure (1) .
12-Effect of treatment of different drug therapies on non organic (ash weight) components of the bone:
There were significant lower levels of ash weights of the OVX, OVX+Ca and OVX+P treated groups compared to the control group. Other ovariectomized treated groups had bone ash levels similar to those of the control group. This is shown in fig. (2). The results obtained in the present study demonstrated that OVX induced a significant decrease in BMD and the femoral BMD of OVX rats was 15.5 % lower than that of control group and that finding is matched with that of Kruger et al. 22 and Hidaka et al. 23 who concluded that ovariectomy resulted a significant reduction in BMD.
The present study demonstrated that the dry weight, ash content and organic matrix weight of left femurs of OVX group were significantly lower than that of the control group, indicating that there was a decrease in bone mass rather than a decrease in bone minerals. Similar 30&31 who reported that estrogen deficiency after OVX reduced the synthesis and release of calcitonin, while chronic treatment with estrogen had a positive effect on calcitonin secretory activity in thyroid C cells of OVX rats.
In the present study, the highest increase in BMD was observed among the combination groups which were supplemented either with estrogen and progesterone or with calcitonin and calcium. This may suggest that the antiresorptive action of estrogen and progesterone could be mediated apart by an increase in calcitonin levels.
The 35 who reported that in ovariectomized rat supplemented with progesterone, bone mass was protected by high level of progesterone present. This finding however, was in disagreement with that of Roux et al. 36 who found that dydrogesterone did not prevent bone loss due to ovariectomy in rats.
The results obtained in the present study demonstrated that plasma parathormone showed insignificant change in the ovariectomized and the ovariectomized treated groups compared with the control group. These results are matched with those of Vincent et al. 37 who reported that estrogen treatment or withdrawal had no significant effect on either basal or stimulated PTH secretion.
Calcitonin replacement in the present work decreased serum calcium, increased partially BMD and increased significantly bone dry weight, organic matrix weight, ash content and ash calcium of left femurs as compared to OVX group. These findings are in agreement with those of Zaidi et al. 38 who reported that calcitonin lowers serum calcium concentrations by decreasing bone resorption and increasing urinary calcium excretion and, also, those of Zake et al. 39 reported who that after treatment of OVX rats with calcitonin, bone density gave partial improvement and bone ash headed towards normal ranges in comparison with group of OVX rats without calcitonin supplementation.
Kavuncu et al., 4 reported that calcitonin treatment resulted in an increase in spinal BMD and the effect of CT on bone structure in vivo appears to be dependent on the rate of bone turnover at the time of treatment. Treatment of OVX rats immediately following the operation with calcitonin for 6 weeks prevented the development of osteoprosis. Calcitonin induced-effect may be explained probably through its binding to osteoclasts receptors (38) . This binding leads to loss of the ruffled border, cessation of motility and inhibition of osteoclastic secretion of proteolytic enzymes and the proton pump. Chronic administration of calcitonin reduces the number of osteoclasts (40) . It is a potent inhibitor of osteoclastic bone resorption and has been reported to exert analgesic effects, properties which have led to its use as a treatment for postmenopausal osteoporosis (41) . Despite a fall in serum calcium in OVX Calcitonin treated group, there was no effect of ovariectomy on PTH. These data suggest that the decrease in ionized calcium was insufficient to produce a response from the parathyroid gland. In a previous study by Mason and Morris 42 who studied the effect of hypocalcemia on PTH secretion in ovariectomized rats found that serum levels of PTH were only increased when blood ionized calcium levels fell below 5.2 mg/dl.
The results obtained in the present study demonstrated that calcium supplementation alone did not produce any increase in bone density in ovariectomized rats. This could suggest that calcium deposition in bone could be dependent on calcitonin level which was decreased by ovariectomy. Ku et al., 43 reported that estrogen deficiency decreases intestinal calcium absorption and the positive effect of calcium does in menopause is more related to building peak bone mass before the onset of menopause and doesn't affect the quantity of bone lost during the initial years of menopause.
In the present study, it was found that calcium potentiated the effect of calcitonin on bone mass that ovariectomized calcitonin and calcium treated female group had better effect on bone mass than calcitonin therapy alone. These findings are in agreement with Nieves et al. 44 who reported that additional calcium to standard antiresorptive therapy can benefit bone mass.
The results obtained in the present study demonstrated that active vitamin D 3 increased bone density in ovariectomized rats. This finding is in agreement with Shibata et al. 45 
